Infrastructure: IMI CIB promotes dialogue in London on the UK's €846 billion plan
LONDON, July 15, 2025 (GLOBE NEWSWIRE) -- The IMI Corporate & Investment Banking Division of Intesa Sanpaolo hosted the conference 'Infrastructure and Growth Opportunities for Europe and the UK: Focus on the UK Infrastructure Strategy' in London, bringing together institutions, companies and investors to discuss the growth prospects linked to the United Kingdom's new ten-year infrastructure plan.
'Intesa Sanpaolo is playing a catalytic role in supporting investments alongside institutions, corporates, funds and investors to support the key projects of the United Kingdom's new 10-year infrastructure plan. Financing sustainable infrastructure, while supporting the so-called twin transition (green and digital), will continue to be a strategic pillar of the IMI CIB Division's strategy.'
Mauro Micillo, Chief of the IMI CIB Division at Intesa Sanpaolo
The United Kingdom's Plan outlines investments of more than €846 billion between 2025 and 2035, centred on three strategic pillars:
infrastructure works
energy transition
enhancement of social and environmental systems.
The Conference stems from the belief that a constructive public-private dialogue is key to accelerating projects that strengthen the competitiveness of the United Kingdom and Europe.
In 2024 alone, global project finance volumes surpassed €300 billion, with transactions involving Intesa Sanpaolo's IMI CIB Division representing around €45 billion — nearly 15% of the global total.
IMI Corporate & Investment Banking Division's Activities in the United Kingdom
The London branch of Intesa Sanpaolo's IMI Corporate & Investment Banking Division serves as the main hub for the UK & MEA Region, which also includes operations in Dubai, Abu Dhabi, Doha, and Istanbul.
In 2024, total financing volumes for corporate and financial institution clients in the Region amounted to approximately €8.5 billion (as of 31/12/2024).
Since 2023, the IMI CIB Division has participated in numerous international transactions originating in the United Kingdom, supporting transition and innovation, for a total value of approximately €11 billion.
Key projects supported by the IMI CIB Division include:
CO₂ transport and storage – Liverpool Bay T&S.
Acquisition of National Grid Transmission by Macquarie AM.
Renewables and energy efficiency operations with TRIG and SEEIT.
These initiatives confirm the Intesa Sanpaolo Group's ongoing commitment to enabling sustainable and digital transformation, in line with the Group's 2022–2025 Business Plan
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
an hour ago
- CTV News
‘I'm going to miss it': Another rural bank branch shuttered near London
West Lorne residents are upset that the town's only bank is permanently closing. CTV London's Sean Irvine has the details.
Globe and Mail
3 hours ago
- Globe and Mail
STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025
DUBLIN, IRELAND, July 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ('STERIS' or the 'Company') announced today that it will host a conference call to discuss its fiscal 2026 first quarter results at 9:00 a.m. ET on August 7, 2025. The conference call can be heard live at or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after the U.S. market closes on August 6, 2025. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on August 7, 2025, either at or via phone. To access the replay of the call, please use the access code 2889488 and dial 1-877-344-7529 in the United States or 1-412-317-0088 internationally. About STERIS STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit Company Contact: Julie Winter, Vice President, Investor Relations and Corporate Communications Julie_Winter@ +1.440.392.7245 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This release and the referenced conference call may contain statements concerning certain trends, expectations, forecasts, estimates, or other forward-looking information affecting or relating to STERIS or its industry, products or activities that are intended to qualify for the protections afforded 'forward-looking statements' under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date the statement is made and may be identified by the use of forward-looking terms such as 'may,' 'will,' 'expects,' 'believes,' 'anticipates,' 'plans,' 'estimates,' 'projects,' 'targets,' 'forecasts,' 'outlook,' 'impact,' 'potential,' 'confidence,' 'improve,' 'optimistic,' 'deliver,' 'orders,' 'backlog,' 'comfortable,' 'trend,' and 'seeks,' or the negative of such terms or other variations on such terms or comparable terminology. Many factors could cause actual results to differ materially from those in the forward-looking statements including, without limitation, those identified in STERIS's recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Other potential risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements include, without limitation: (a) operating costs, pressure on pricing (including, without limitation, as a result of inflation), Customer loss and business disruption (including, without limitation, difficulties in maintaining relationships with employees, Customers, clients or suppliers) being greater than expected and leading to erosion of profit margins; (b) STERIS's ability to successfully integrate acquired businesses into its existing businesses, including unknown or inestimable liabilities, impairments, or increases in expected integration costs or difficulties in connection with the integration of such businesses; (c) changes in tax laws or interpretations or the adoption of certain income tax treaties in jurisdictions where we operate that could increase our consolidated tax liabilities, including changes in tax laws that would result in STERIS being treated as a domestic corporation for United States federal tax purposes, or tariffs and/or other trade barriers; (d) the possibility that compliance with laws, court rulings, certifications, regulations, or other regulatory actions, or the outcome of any pending or threatened litigation, including the Isomedix litigation, may delay, limit or prevent new product or service introductions, impact production, supply and/or marketing of existing products or services, result in uncovered costs, or otherwise affect STERIS's performance, results, prospects or value; (e) the potential of international unrest, including military conflicts, economic downturn and effects of currency fluctuations; (f) the possibility of delays in receipt of orders, order cancellations, or the manufacture or shipment of ordered products; (g) the possibility that anticipated growth, performance or other results may not be achieved, or that timing, execution, impairments, or other issues associated with STERIS's businesses, industry or initiatives may adversely impact STERIS's performance, results, prospects or value; (h) the impact on STERIS and its operations of any legislation, regulations or orders, including but not limited to any new trade, regulations or orders, that may be implemented by the U.S. administration or Congress, or of any responses thereto by non-U.S. governments; (i) the possibility that anticipated financial results, anticipated revenue, productivity improvements, cost savings, growth synergies, and other anticipated benefits of acquisitions, restructuring efforts, and divestitures will not be realized or will be less than anticipated; (j) the level of STERIS's indebtedness limiting financial flexibility or increasing future borrowing costs; (k) the effects of changes in credit availability and pricing, as well as the ability of STERIS and STERIS's Customers and suppliers to adequately access the credit markets, on favorable terms or at all, when needed; (l) the impacts of increasing competition within our industry, which may exert pressure on our pricing strategy or lead to decreasing demand for our products and services; (m) the effects on our operations resulting from labor-related issues, such as strikes, unsuccessful union negotiations and other workforce disruptions; (n) the possibility of economic downturns and recessions, which could negatively impact our business by reducing consumer and Customer spending. Unless legally required, STERIS does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized.
Globe and Mail
4 hours ago
- Globe and Mail
Contra Guys: It can be advantageous to cast a wide – and global
How much of your portfolio is invested overseas? This is an important question, especially in a year such as this one, when many European stock indexes are beating North American benchmarks, including the S&P/TSX Composite Index. Though many Canadians are overweight in Canadian stocks, we remain true to our contrary roots and try to avoid home-country bias. Investing in our home market can have certain tax advantages, and avoids foreign exchange rate volatility, but it can also reduce diversification, increase risk and impact returns. Ultimately, it is a big world out there, and it can be advantageous to cast a wide net. This is why we make a habit of investing in exchange-traded funds and equities that do business around the globe. One such ETF is the Global X MSCI Greece ETF GREK-A, which tracks the performance of the MSCI All Greece Select 25/50 Index. Here at Contra the Heard Investment Newsletter, we took a stake in GREK in October, 2015. Back then, the Greek financial crisis was rumbling into its seventh year and few investors wanted to touch the country. The government had just negotiated its third bailout package, introduced capital controls and then-Prime Minister Alexis Tsipras had won a surprise re-election. These actions tempered the surging value of credit default swaps and yields on government debt, but the nation remained on the cusp of default. Gross domestic product had fallen from US$352.1-billion in 2008 to US$194.6-billion in 2015, the unemployment rate was around 25 per cent and the banking sector was on life support, as roughly 47 per cent of all loans were non-performing. To illustrate just how bad the Hellenic banking crisis was, during the peak of the 2008-09 U.S. financial crisis, America's non-performing loans were only 7.5 per cent. Amid these economic depression-like conditions, the Greek stock market sank to one of the cheapest in the world and we took a stake. Not only was it inexpensive, but we figured the Troika (a decision-making group composed of the European Commission, European Central Bank and International Monetary Fund) would not let Greece fail. The Troika had already bailed out the country three times and, within the context of the European Union, Greece was too big to fail. Once the ETF was in our portfolio, we practised patience. While corporate turnarounds take time, national ones can take even longer. In 2023, I wrote about the Greek ETF for The Globe and Mail. At the time, I argued the ETF was still cheap and the country was performing well thanks to a series of reforms that had cut the national debt, streamlined regulations, reduced tax avoidance, digitized government processes and put the banks back on their feet. Earlier: Greece's stock market is on a tear - and this ETF tracking it is poised for even more gains Fast forward to the present day and the turnaround has turned into a growth story. Greece regained an investment-grade credit rating in late 2023, the country's debt-to-GDP ratio has fallen from more than 200 per cent to 153.6 per cent and it produced a budgetary surplus of 1.3 per cent of GDP in 2024. By contrast, the euro zone average was a deficit of 3.1 per cent. The Greek government surplus is even more impressive given that most European countries have been spending just over 2 per cent of GDP on defence while Greece spent approximately 3.1 per cent last year. This should serve Greece well as the North Atlantic Treaty Organization alliance moves toward a new 5-per-cent target. Aside from government finances, the rest of Greece's economy is doing well too. The unemployment rate has fallen to under 8 per cent, the household-debt-to-GDP ratio has fallen from nearly 67 per cent to 39 per cent since the financial crisis and the financial sector's non-performing loan balance now stands at under 4 per cent. The banks have done so well that they now account for more than half of the GREK ETF versus around a quarter a decade ago. Despite all the success, Greece is not without risk. The debt-to-GDP ratio is still high, the nation continues to score poorly on the Corruption Perception Index despite recent advances and it has continuing problems with its neighbours in Turkey. The legal system is also a congested and inefficient mess. According to the EU Justice Scoreboard, it takes Greek courts over 600 days to conclude civil and commercial cases. By contrast, Denmark takes less than 20 days and most European countries take around 100 days. This means it can take years for a trial to reach a conclusion – assuming there is no appeal. These timelines slow down business, drive away foreign investment and leave parties impacted by court cases in a state of limbo. At its core, Greece faces poor demographics as well. The nation's fertility rate is roughly 1.3 births per woman, it suffered years of net emigration during the financial crisis and the median age, currently in the mid-40s, is climbing fast. This means that Greece's population, which peaked over a decade ago, is expected to fall in the decades ahead. Moreover, Greek society will get materially older; this will leave fewer working-age people to support retirees, health care infrastructure and pensions. All in all, however, Greece has more going for it than against it, and the turnaround over the past decade has been a resounding success. The outlook is positive and the GREK ETF could rally much further. We recently trimmed our position in GREK for a 109.2-per-cent gain. Locking in this profit recouped our initial investment but leaves plenty of skin in the game to benefit from future price appreciation. Today, GREK sports a yield of over 4 per cent and blends strong momentum with low stock valuations. These are excellent characteristics, especially when coupled with the underlying economic conditions. Our plan is to let the ETF run, look for valuations to increase further and sell the rest of our stake in slices. Once it is sold entirely, we will continue to avoid home-country bias, deploy the winnings in a new overseas investment and, with any luck, repeat the success. Philip MacKellar is the general manager at Contra the Heard Investment Newsletter.
